Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the clinical efficacy of 3% (w/w) GW842470X cream
applied to involved skin of adult patients with moderate atopic dermatitis using the Eczema
Area Severity Index (EASI) assessment of disease severity and to investigate the safety of
and tolerability of 3% GW842470X cream on diseased skin of adult patients.